简单的LSDD环类比:对结构-活动关系及其作为治疗药物的潜力进行考虑
1Department of Comparative Biomedical Sciences, Louisiana State University, Baton Rouge, Louisiana 70803, United States.
ACS chemical neuroscience
|November 5, 2025
概括
研究人员正在开发非幻觉性迷幻类类似物来治疗精神疾病. 简单的LSDD环类似物在动物中阻断迷幻效应方面表现有前途,这需要进一步研究治疗潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 药用化学 医学化学
背景情况:
- 迷幻药物显示治疗潜力,但引起主观体验.
- 研究正在创造非幻觉类类似物来治疗精神病和神经退行性疾病.
- LSD的结构-活动关系 (SAR) 指导模拟开发.
研究的目的:
- 检查LSD D环类型的开发和测试.
- 评估这些类似物作为非幻觉性治疗剂的潜力.
- 探索相关化合物中增强治疗效果的修改.
主要方法:
- 对LSD D环类别的历史发展进行了回顾.
- 在动物模型中对类似物进行行为测试.
- 结构与活动关系的分析.
主要成果:
- 在目前的测试中,简单的LSD D-环类比物是非幻觉性和无毒的.
- 这些类似物可以阻断精神类药物在动物中的行为破坏作用.
- 成熟的数据表明治疗潜力,但需要进一步验证.
结论:
- 在精神和神经疾病中,LSD D-环类似物可能具有治疗效益.
- 需要进一步的研究来评估结合性,塑性效应和临床效用.
- SAR数据表明,结构修改可以在试验中增强其他LSD类似物.
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Principles of Drug Action
8.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
8.0K
CNS Stimulants: Psychedelic Agents
660
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
660
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
2.0K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
2.0K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
898
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
898

![Solid-phase Synthesis of [4.4] Spirocyclic Oximes](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58508.jpg&w=3840&q=50)
